Jump to content
Main menu
Main menu
move to sidebar
hide
Navigation
Main page
Recent changes
Random page
Help about MediaWiki
Special pages
Niidae Wiki
Search
Search
Appearance
Create account
Log in
Personal tools
Create account
Log in
Pages for logged out editors
learn more
Contributions
Talk
Editing
Bausch & Lomb
(section)
Page
Discussion
English
Read
Edit
View history
Tools
Tools
move to sidebar
hide
Actions
Read
Edit
View history
General
What links here
Related changes
Page information
Appearance
move to sidebar
hide
Warning:
You are not logged in. Your IP address will be publicly visible if you make any edits. If you
log in
or
create an account
, your edits will be attributed to your username, along with other benefits.
Anti-spam check. Do
not
fill this in!
===Company developments in recent years=== Since then, Bausch & Lomb has developed into a globally operating company which is one of the largest producers of contact lenses. As of 2022, about 12,900 employees in approximately 100 countries work for the firm.<ref name="sec10k2022"/> Competitors in the international eye care products market are [[Johnson & Johnson]], [[Allergan]], [[Alcon]], [[Merck & Co.|MSD-Chibret]], [[CooperVision]], Menicon Co., [[Hoya Corporation]], [[EssilorLuxottica]] and [[Carl Zeiss Meditec]].<ref name="fortune"/> In 2023, Bausch + Lomb Corp announced it would it would buy [[Xiidra]] from Novartis for $1.75 billion and pay additional $750 million in linked to future sales for Xiidra as well as two pipeline asset.<ref>{{Cite news |date=2023-06-30 |title=Bausch + Lomb to buy Novartis dry-eye drug for $1.75 bln |language=en |work=Reuters |url=https://www.reuters.com/markets/deals/bausch-lomb-buy-dry-eye-drug-novartis-175-billion-wsj-2023-06-30/ |access-date=2023-06-30}}</ref><ref>{{Cite news |date=2023-06-30 |title=Novartis Sells Eye Drugs to Bausch + Lomb for Up to $2.5 Billion |language=en |work=Bloomberg.com |url=https://www.bloomberg.com/news/articles/2023-06-30/novartis-sells-eye-drugs-to-bausch-lomb-for-up-to-2-5-billion |access-date=2023-06-30}}</ref> {| class="wikitable" |+ '''Chief executives''' |- ! Name ! Title ! Tenure |- | [[John Jacob Bausch]] | President | 1885β1926 |- | [[Edward Bausch]] | President | 1926β1935 |- | M. Herbert Eisenhart | President | 1935 β December 1950 |- | Joseph F. Taylor | President | January 1951 β November 1954 |- | Carl S. Hallauer | President | November 1954 β March 1959 |- | William W. McQuilkin | President | March 1959 β May 1971 |- | Jack D. Harby | President | May 1971 β |- | Daniel G. Schuman | CEO | β April 1981 |- | Daniel E. Gill | CEO | April 1981 β December 1995 |- | William M. Carpenter | CEO | 1996 β June 1998 |- | Ron Zarella | CEO | 2001β2008<ref>{{cite web|url=http://readwrite.com/2012/05/03/10-executives-who-lied-on-their-resumes-and-2-who-got-away-with-it|title=10 Executives Who Lied On Their Resumes - And 2 Who Got Away With It - ReadWrite|date=3 May 2012}}</ref> |- | Gerald Ostrov | CEO | 2008 β March 2010<ref>{{cite news|url=http://archive.boston.com/business/articles/2010/03/15/new_ceo_chairman_appointed_at_bausch__lomb/|title=New CEO, chairman appointed at Bausch & Lomb|first=Ben|last=Dobbin|newspaper=Boston.com|date=15 March 2010|via=The Boston Globe}}</ref> |- | [[Brent Saunders]] | CEO | February 2010 β August 2013 |- | [[Joseph C. Papa]] | CEO | May 2016 β March 2023 |- | Brent Saunders | CEO | March 2023 β present<ref>{{cite news |url=https://www.wsj.com/articles/bausch-lombs-ceo-inks-first-big-deal-since-return-5f2ec13 |title=Bausch + Lomb's CEO Inks First Big Deal Since Return |date=30 June 2023 |work=[[The Wall Street Journal]] |last=Hopkins |first=Jared S.}}</ref> |}
Summary:
Please note that all contributions to Niidae Wiki may be edited, altered, or removed by other contributors. If you do not want your writing to be edited mercilessly, then do not submit it here.
You are also promising us that you wrote this yourself, or copied it from a public domain or similar free resource (see
Encyclopedia:Copyrights
for details).
Do not submit copyrighted work without permission!
Cancel
Editing help
(opens in new window)
Search
Search
Editing
Bausch & Lomb
(section)
Add topic